- Home
- WTI vs ABEO Comparison
WTI vs ABEO Comparison
Compare WTI & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- ABEO
- Stock Information
- Founded
- WTI 1983
- ABEO 1974
- Country
- WTI United States
- ABEO United States
- Employees
- WTI N/A
- ABEO N/A
- Industry
- WTI Oil & Gas Production
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- WTI Energy
- ABEO Health Care
- Exchange
- WTI Nasdaq
- ABEO Nasdaq
- Market Cap
- WTI 276.1M
- ABEO 256.9M
- IPO Year
- WTI 2005
- ABEO 1980
- Fundamental
- Price
- WTI $1.81
- ABEO $5.69
- Analyst Decision
- WTI
- ABEO Strong Buy
- Analyst Count
- WTI 0
- ABEO 6
- Target Price
- WTI N/A
- ABEO $18.00
- AVG Volume (30 Days)
- WTI 3.9M
- ABEO 1.1M
- Earning Date
- WTI 08-05-2025
- ABEO 08-11-2025
- Dividend Yield
- WTI 2.21%
- ABEO N/A
- EPS Growth
- WTI N/A
- ABEO N/A
- EPS
- WTI N/A
- ABEO N/A
- Revenue
- WTI $514,341,000.00
- ABEO N/A
- Revenue This Year
- WTI $3.30
- ABEO N/A
- Revenue Next Year
- WTI $3.29
- ABEO $323.51
- P/E Ratio
- WTI N/A
- ABEO N/A
- Revenue Growth
- WTI N/A
- ABEO N/A
- 52 Week Low
- WTI $1.09
- ABEO $3.93
- 52 Week High
- WTI $2.84
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- WTI 51.28
- ABEO 47.54
- Support Level
- WTI $1.75
- ABEO $5.68
- Resistance Level
- WTI $1.86
- ABEO $5.93
- Average True Range (ATR)
- WTI 0.13
- ABEO 0.26
- MACD
- WTI -0.02
- ABEO -0.01
- Stochastic Oscillator
- WTI 22.08
- ABEO 56.25
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.